- 24 (7): 590–598. doi:10.1111/ajad.12291. PMID 26346395. S2CID 22703103.
Boutrel B, Koob GF (September 2004). "What
keeps us awake: the neuropharmacology...
- Clin. 15 (2): 177–194. doi:10.1016/j.jsmc.2020.02.006. PMID 32386693.
Boutrel B, Koob GF (September 2004). "What
keeps us awake: the neuropharmacology...
- from the
concept of "vigilance-promoting" to "wakefulness-promoting".
Boutrel B, Koob GF (September 2004). "What
keeps us awake: the neuropharmacology...
- Clin. 25 (6): 376–385. doi:10.1016/0987-7053(96)84911-2. PMID 8904200.
Boutrel B, Koob GF (September 2004). "What
keeps us awake: the neuropharmacology...
- Reviews. 13 (5): 363–77. doi:10.1016/j.smrv.2008.12.003. PMID 19345124.
Boutrel B, Koob GF (September 2004). "What
keeps us awake: the neuropharmacology...
- doi:10.1016/j.neuropharm.2023.109546. PMID 37068603. Koob GF,
Ahmed SH,
Boutrel B, Chen SA,
Kenny PJ,
Markou A, O'Dell LE,
Parsons LH,
Sanna PP (January...
- 2006.11.008. PMID 17182090. S2CID 8186943.
Specio SE, Wee S, O'Dell LE,
Boutrel B,
Zorrilla EP, Koob GF (February 2008). "CRF(1)
receptor antagonists attenuate...